UNSPSC 41131909: Erythrocyte sedimentation rate test

In this classification, Erythrocyte sedimentation rate test connotes a device used to measure the length of time required for the red cells in a blood sample to fall a specified distance or a device that measures the degree of sedimentation taking place in a given length of time. An increased rate indicates tissue damage or inflammation. US FDA regulates Erythrocyte sedimentation rate test under 21 CFR 864.6700 and under FDA product code JPH.

UNSPSC 41131909 Erythrocyte sedimentation rate test is a Commodity code that covers laboratory consumables, equipment, and proficiency testing materials used in clinical hematology and blood chemistry analysis. State and local governments procure under this code the analytical instruments, replacement parts, chemical reagents, and quality-assurance testing samples required to operate and maintain hematology labs in public health departments, university research facilities, and state health agencies. The issuing bodies soliciting under the code include state health departments and university systems; the Texas Health and Human Services Commission and Department of State Health Services appear as repeat buyers in recent activity.

Recent opportunities show activity concentrated in Texas and Wisconsin. The Texas Health and Human Services Commission issued an IFB (HHS0017310, due May 18, 2026) for a D-10 Hemoglobin Testing System with Rack Loader, including an ion-exchange HPLC analyzer and sample-loading accessories rated for 50 automated samples, to replace end-of-life equipment at the South Texas Lab in Harlingen; historical spend guidance for similar goods ranged $45,050 to $80,000 in fiscal year 2025. HHSC also posted an IFB (HHS0017071, due March 5, 2026) for PerkinElmer ICP-MS consumables and supplies — sample probes, filters, cones, nebulizers, torches, tubing, and solutions — used in pediatric blood lead screening, with historical spend of $20,000 to $30,000. The University of Wisconsin-Madison issued a competitive bid (2026-UWMSN-01287-RFB, due April 21, 2026) for custom-made Hematology/Whole Blood Chemistry proficiency testing samples for quality assurance. None of these solicitations carried set-aside designations for disadvantaged enterprises, though the Texas procurements encouraged HUB subcontracting plans. All three were open competitive procurements with no incumbent vendor identified.